3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Stomach Neoplasms
14
Peritoneal Neoplasms
10
Ovarian Neoplasms
8
Fallopian Tube Neoplasms
5
Colorectal Neoplasms
4
Carcinoma, Ovarian Epithelial
4
Neoplasm Metastasis
3
Appendiceal Neoplasms
3
Pancreatic Neoplasms
2
Neoplasms
2
Mesothelioma
2
Hyperthermic Intraperitoneal Chemotherapy
2
Gastric Adenocarcinoma
2
Carcinoma
2
Wilms Tumor
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Sarcoma
1
Recurrence
1
Pseudomyxoma Peritonei
1
Peritoneal Diseases
1
Malignant Neoplasm of Colorectum
1
Locally Advanced Gastric Cancer
1
Gastrointestinal Neoplasms
1
Gastric Cancer Peritoneal Metastases
1
Exploratory Behavior
1
Drug-Related Side Effects and Adverse Reactions
1
Desmoplastic Small Round Cell Tumor
1
Clinical Stage I Gastric Cancer AJCC v8
1
Interventions
Oxaliplatin
10
Capecitabine
9
Cisplatin
8
Fluorouracil
5
Leucovorin
4
Bevacizumab
4
tegafur-gimeracil-oteracil
3
pemigatinib
3
atezolizumab
3
Nivolumab
3
trebananib
2
ponatinib
2
pembrolizumab
2
avelumab
2
apatinib
2
alectinib
2
XELOX
2
Standard of Care
2
S 1 (combination)
2
Radiotherapy
2
Radiosurgery
2
Ocoxin
2
Irinotecan
2
Ipilimumab
2
Gemcitabine
2
Folfox protocol
2
Everolimus
2
Erlotinib Hydrochloride
2
Acupuncture Therapy
2
zanidatamab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Gastrointestinal Neoplasms
×
Hyperthermic Intraperitoneal Chemotherapy
×
Clear all
NCT02349958
2019-04-16
HIPEC/IPHC
Bay Area Gynecology Oncology
Phase 2
Unknown
200 enrolled